What does a blast look like on a peripheral blood smear or bone‑marrow aspirate?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 15, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

What Does a Blast Look Like?

Morphologic Definition

Blasts are immature hematopoietic cells characterized by a high nuclear-to-cytoplasmic ratio, easily visible nucleoli, fine nuclear chromatin, and variable cytoplasmic basophilia, with or without granules or Auer rods but no Golgi zone. 1

Key Identifying Features

Nuclear Characteristics

  • Fine, delicate chromatin pattern that appears open and lacy, distinctly different from the coarse, clumped chromatin of mature cells 1
  • Prominent nucleoli that are easily visible and well-defined 1
  • Round to oval nuclear shape with smooth nuclear contours in most cases 1

Cytoplasmic Features

  • High nuclear-to-cytoplasmic ratio meaning the nucleus occupies most of the cell with only a thin rim of cytoplasm 1
  • Basophilic (blue) cytoplasm of variable intensity on Wright-Giemsa staining 1
  • Absence of a Golgi zone (the pale perinuclear clearing seen in more mature cells like promyelocytes) 1
  • Variable presence of azurophilic granules or Auer rods (crystallized primary granules pathognomonic for myeloid lineage) 1

Critical Distinctions from Blast Mimics

Common Pitfalls to Avoid

Proerythroblasts can be mistaken for blasts but typically have more intensely basophilic cytoplasm and may show early hemoglobinization 1

Lymphoid cells (particularly hematogones and reactive lymphocytes) may resemble blasts but usually have denser chromatin and less prominent nucleoli 1

Promyelocytes are NOT blasts despite being immature; they have a visible Golgi zone and abundant primary granulation 1

Practical Counting Guidelines

Peripheral Blood Assessment

  • Count a minimum of 500 cells on the peripheral blood smear to ensure reliable blast percentage determination 2
  • Normal individuals have <1% blasts in peripheral blood, with most showing 0% 3
  • Any circulating blasts warrant immediate hematology consultation and bone marrow examination 2

Bone Marrow Assessment

  • Count at least 500 nucleated cells in bone marrow aspirate smears, including at least 100 erythroblasts and 30 megakaryocytes 1
  • Blasts in normal or reactive marrows are scattered or adjacent to bone trabeculae or blood vessels 1
  • Leukemic blasts tend to form aggregates or clusters in abnormal central marrow cavity locations (ALIP - abnormally localized immature precursors) 1

Diagnostic Thresholds

Clinical Significance of Blast Percentages

  • <1% peripheral blood blasts: Normal finding 3
  • 2-4% peripheral blood blasts: Diagnostic for RAEB-1 (Refractory Anemia with Excess Blasts-1) when other MDS features present 2, 3
  • 5-19% peripheral blood blasts: Diagnostic for RAEB-2 2
  • ≥20% peripheral blood or bone marrow blasts: Diagnostic threshold for acute myeloid leukemia 2, 3

Ancillary Identification Methods

Immunohistochemistry

CD34 immunostaining is particularly valuable in hypocellular or fibrotic bone marrow specimens where morphologic assessment is inadequate 1, 2

Additional useful markers include CD117, myeloperoxidase, lysozyme, and CD68 for identifying and characterizing blasts in tissue sections 1

Flow Cytometry

Flow cytometry provides immunophenotypic characterization but morphologic blast percentage takes precedence over flow cytometry for prognostic stratification 2

Hemodilution of bone marrow specimens (particularly in fatty or fibrotic marrows) can artificially lower blast percentages by flow cytometry 1

Location and Distribution Patterns

In bone marrow biopsies, blasts forming aggregates of >5 cells or clusters of 3-5 cells in abnormal central locations (ALIP-positive) indicate aggressive MDS subtypes with poor prognosis and increased progression to acute leukemia 1

At least three such aggregates or clusters must be identified in a histology section to classify as ALIP-positive 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Diagnostic Criteria for Hematological Malignancies

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Blast Percentage in Peripheral Blood

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Related Questions

What is the appropriate management for a patient with leukopenia, anemia, and blasts in the peripheral blood?
What are the diagnostic tests and treatment options for leukaemia?
Which test is not primarily used for diagnosing Acute Lymphoblastic Leukemia (ALL)?
What percentage of blasts in peripheral blood is considered significant for a diagnosis of acute leukemia?
What is the immediate management for a patient with elevated Lactate Dehydrogenase (LDH) and 37% blasts in the blood?
When interpreting an arterial blood gas, should I use the calculated bicarbonate from the ABG or the standard serum bicarbonate?
Should furosemide (Lasix) be held in a hypotensive patient admitted for acute decompensated heart failure with volume overload, and what is the underlying pathophysiology?
What condition is suggested by several weeks of conjunctival injection followed by a month of painful dry eye?
What is the appropriate work‑up for low dehydroepiandrosterone sulfate (DHEA‑S) and pregnenolone in an adult male?
In a patient with extensive burns (>20% total body surface area) who has rhabdomyolysis (creatine kinase >5,000 U/L) or hemoglobinuria, what are the indications, timing, dosing regimen, monitoring parameters, and contraindications for initiating alkaline diuresis?
How should I manage resistant hypertension in a 54‑year‑old post‑menopausal woman on oral estradiol, amphetamine stimulant, atenolol, amlodipine, and telmisartan who has brain fog, painful peripheral edema, and worsening mood?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.